Scientists identify enigmatic aggregates linked to neurodegenerative diseases

Magdeburg/London, January 18th, 2013. The brain can recall memories faster than previously assumed. A team of experts under the direction of neuroscientist Emrah Düzel, who is based in Magdeburg, Germany, was able to show this through a series of memory tests.…

From January 2013: New site speaker at DZNE Witten

Federal Minister Schavan inaugurates new DZNE and University of Ulm institutes

Bonn, December 20th, 2012. Scientists at the German Center for Neurodegenerative Diseases (DZNE) in Bonn have gained new insights into the early phase of the brain’s development. In cooperation with researchers of the Max Planck Institute of Neurobiology,…

Bonn, December 19th, 2012. Researchers in Bonn, Germany, have identified a protein as a potential target for the treatment of Alzheimer’s disease. The molecular complex is part of the immune system and a driving force for inflammatory responses of the brain.…

Collaboration between two Helmholtz Centres: Neuroscientists and infection researchers focus on interdisciplinary partnership to study brain diseases

DZNE researchers are studying movement disorders within the framework of the EU's NEUROMICS project

Göttingen, November 30th, 2012. Researchers at the German Center for Neurodegenerative Diseases (DZNE) and the University Medical Center Göttingen (UMG) have identified an enzyme as a possible target for the treatment of Alzheimer’s disease. The protein known as…

Joint Press Release of the German Center for Neurodegenerative Diseases and the Max Planck Research Unit for Enzymology of Protein Folding